⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMGN News
Amgen Inc
Regenexx Pain Solution Center Bangladesh Launches Advanced Regenerative Rheumatology Program, Introducing Breakthrough Non-Surgical Pain Relief and Autoimmune Care In Bangladesh & Globally
accessnewswire.com
NVS
PFE
AZN
ABBV
LLY
GSK
AMGN
Debbie's Dream Foundation: Curing Stomach Cancer Thanks Its 2025 Industry Partners for Advancing Critical Programs and Patient Support
prnewswire.com
AMGN
BMY
ARCX
AZN
GILD
JAZZ
LLY
MRK
ASTL
THTX
Tigerlily Foundation Launches RACE Alliance - Putting Community First
prnewswire.com
AMGN
DNA
AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS
prnewswire.com
AMGN
Hack Your DNA Explained: How the Behind the Markets Newsletter Subscription Is Presented to Readers
accessnewswire.com
AMGN
PLTR
IONQ
Is SkinnyRx the Best GLP-1 Vendor for 2026? Platform Offers Compounded Semaglutide in Three Forms Starting at $199/Month as New Year Weight Loss Season Approaches
globenewswire.com
WGO
AMGN
LLY
Chemotherapy Induced Anemia Market Intelligence Report 2025-2032, Featuring Amgen, Johnson & Johnson, Pfizer, Biocon, Intas Pharmaceuticals, Viatris and More - ResearchAndMarkets.com
businesswire.com
AMGN
JNJ
PFE
VTRS
Peptide Therapeutics Market Size to Surpass USD 87.21 Billion by 2035 Driven by Rising Cancer, Diabetes, and Demand for Targeted Therapies
globenewswire.com
LLY
AMGN
PFE
Der Global Power City Index 2025 der Mori Memorial Foundation sieht aufgrund von Tourismusgewinnen in Ostasien und Inflationsdruck im Westen Verschiebungen im Städte-Ranking
businesswire.com
NWS
NYT
MSFT
GOOG
AMZN
JPM
GS
MS
IBM
INTC
NVDA
META
AAPL
AMGN
BIIB
GILD
Disease-Modifying Therapies Market to Surpass USD 112.6 Billion by 2033 as Biologic Innovation Redefines Long-Term Disease Control
prnewswire.com
JNJ
ABBV
AZN
GSK
AMGN